Cognitive Stimulation Therapy (CST) enhances the effects of Alzheimer’s disease medicine
Cognitive Stimulation Therapy (CST) enhances the effects of Alzheimer’s disease medicine A key finding from the recently released 2nd systematic Cochrane review (Woods et al., 2023) is the confirmation that medication combined with CST results […]
First sales contract expanded
Brain+ expands its first sales contract close to doubling it In December 2023 Brain+ closed its first sales contract with Herning Municipality, and Herning has chosen to expand that contract, nearly doubling the contractual size. […]
New Cochrane review confirms CST
New Cochrane review confirms the benefit and relevance of Cognitive Stimulation Therapy (CST) for people with dementia A 2nd systematic Cochrane review, ‘Cognitive stimulation to improve cognitive functioning in people with dementia’ (Woods et al., 2023), […]
CONCLUSION EU PROJECT & VALIDATION OF TWO TECHNOLOGIES
Successful conclusion of EU project Alzheimer’s Detect & Prevent with early validation of two Brain+ DTx technologies and extra funding The information communicated in this announcement is “inside information” for the purposes of article 7 of […]
Brain+ completes Swedish research version of its dementia product
Brain+ completes Swedish research version of its dementia product with the Research Institutes of Sweden and extends the collaboration A strong Swedish partner research network Brain+ has over the last three years entered multiple Alzheimer’s […]
3-Year Innovation Project is Completed
3-year innovation project with the Danish Life Science Cluster is completed with the Brain+ CST-Therapist Companion product as the final output A 3-year collaboration project between VIA University College, MedTech Innovation Consortium (MTIC), and Brain+ […]
Strong Q4 with Product Launch & Successful Capital Raise
Brain+ announces Investor Webinar following strong Q4 with product launch and succesful capital raise Brain+ invites you to an investor webinar after a strong quarter with commercial introduction of its first dementia product, a successful […]
WHO points to CST to solve the dementia burden
A new WHO report points to Cognitive Stimulation Therapy (CST) and digital solutions As means to help solve the global dementia burden The World Health Organization (WHO) recently published a large report, A blueprint For Dementia […]
CST Therapist Companion advancing
Brain+ further advances its first digital dementia product, Cognitive Stimulation Therapy (CST) – Therapist Companion Commercial launch in Denmark will be November 1, 2022 Adaptation of a UK product version for the United Kingdom starts […]